S. 898 · 117th Congress
Fair Accountability and Innovative Research Drug Pricing Act of 2021
- Stage
- In committee
- Sponsor
- Tammy Baldwin
- Introduced
- 2021-03-23
- Latest action
- 2021-03-23 · Introduced in Senate
Summary
Fair Accountability and Innovative Research Drug Pricing Act of 2021
This bill requires manufacturers to report about certain price increases for prescription drugs and biological products with a wholesale cost of at least $100 per month. Such reports must include, among other information (1) the percentage price increase, (2) a justification for such increase, (3) the price history of the drug, (4) the total cost to develop the drug, and (5) the total revenue and net profit generated from the drug.